My Publications

• Journal Article
• Poster/podium
• White Paper
• Clear Filter

2025

• Rege S , Parlett LE , Neikirk AL et al . New diagnoses of juvenile idiopathic arthritis early in the COVID-19 pandemic analysis of a large United States commercial insurance database .J Clin Rheumatol. 2025; 31 (1) : 40-4 . doi: 10.1097/RHU.0000000000002154 .

Return to Year List

2024

• Lewis JD , Brensinger CM , Parlett LE , Hurtado-Lorenzo A , Kappelman MD . Provider specialization in inflammatory bowel diseases: quality of care and outcomes .Clin Gastroenterol Hepatol. 2024; 22 (12) : 2475-86.e14 . doi: 10.1016/j.cgh.2024.05.024 .
• Singh S , Li X , Cocoros NM et al . High-risk medications in persons living with dementia: a randomized clinical trial .Jama Intern Med. 2024; 184 (12) : 1426-33 . doi: 10.1001/jamainternmed.2024.5632 .
• Long MD , Parlett LE , Lewis JD et al . Corticosteroids but not anti-TNF are associated with increased COVID-19 complications in patients with inflammatory bowel disease .Inflamm Bowel Dis. 2024; 30 (8) : 1345–52 . doi: 10.1093/ibd/izad176 .
• Adimadhyam S , Lewis JD , Simon AL et al . Real-world evidence comparing tofacitinib and vedolizumab in anti-TNF-experienced patients with ulcerative colitis .Inflamm Bowel Dis. 2024; 30 (4) : 554-62 . doi: 10.1093/ibd/izad115 .
• Anthony MS , Aroda VR , Parlett LE et al . Risk of anaphylaxis among new users of GLP-1 receptor agonists: a cohort study .Diabetes Care. 2024; 47 (4) : 712-9 . doi: 10.2337/dc23-1911 .
• Singh S , Cocoros NM , Li X et al . Developing a program to educate and sensitize caregivers to reduce the inappropriate prescription burden in the elderly with alzheimer's disease (D-PRESCRIBE-AD): trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial .Plos One. 2024; 19 (2) : e0297562 . doi: 10.1371/journal.pone.0297562 .
• Forrest CB , Chen CP , Perrin EM et al . Pediatric medical subspecialist use in outpatient settings .Jama Netw Open. 2024; 7 (1) : e2350379 . doi: 10.1001/jamanetworkopen.2023.50379 .

Return to Year List

2023

• Dawwas GK , Weiss A , Constant BD et al . Development and validation of claims-based definitions to identify incident and prevalent inflammatory bowel disease in administrative healthcare databases .Inflamm Bowel Dis. 2023; 29 (12) : 1993-6 . doi: 10.1093/ibd/izad053 .
• Horton DB , Yang Y , Neikirk AL et al . Impact of the COVID-19 pandemic on the management of juvenile idiopathic arthritis: analysis of United States commercial insurance data .J Clin Rheumatol. 2023; 29 (8) : 388-95 . doi: 10.1097/RHU.0000000000002035 .
• Lewis JD , Parlett LE , Jonsson Funk ML et al . Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States .Gastroenterology. 2023; 165 (5) : 1197-1205.e2 . doi: 10.1053/j.gastro.2023.07.003 .
• Kappelman MD , Lewis JD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF-experienced patients with crohn's disease initiating vedolizumab versus ustekinumab .Dig Dis Sci. 2023; 68 (8) : 3413-20 . doi: 10.1007/s10620-023-07942-0 .
• Cocoros NM , Gurwitz J , Cziraky MJ et al . Pragmatic guidance for embedding pragmatic clinical trials in health plans: large simple trials aren't so simple .Clin Trials. 2023; 20 (4) : 416-24 . doi: 10.1177/17407745231160459 .
• Kappelman MD , Long MD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib .Crohns Colitis 360. 2023; 5 (3) : otad031 . doi: 10.1093/crocol/otad031 .
• Kappelman MD , Adimadhyam S , Hou L et al . Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with crohn's disease .Am J Gastroenterol. 2023; 118 (4) : 674-84 . doi: 10.14309/ajg.0000000000002068 .
• Horton DB , Neikirk AL , Yang Y et al . Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States .Respir Res. 2023; 24 (1) : 72 . doi: 10.1186/s12931-023-02377-7 .

Return to Year List

2022

• Pokorney SD , Cocoros NM , Al-Khalidi HR et al . Effect of mailing educational material to patients with atrial fibrillation and their clinicians on use of oral anticoagulants: a randomized clinical trial .Jama Netw Open. 2022; 5 (5) : e221432 . doi: 10.1001/jamanetworkopen.2022.14321 .

Return to Year List

2021

• Lo Re 3rd V , Carbonari DM , Jacob J et al . Validity of ICD-10-cm diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies .Pharmacoepidemiol Drug Saf. 2021; 30 (7) : 899-909 . doi: 10.1002/pds.5253 .
• Parlett LE , Ma Q , Shi Q et al . Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus .Diabetol Metab Syndr. 2021; 13 (1) : 47 . doi: 10.1186/s13098-021-00665-0 .

Return to Year List

2020

• Al-Khatib SM , Pokorney SD , Al-Khalidi HR et al . Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: a population being targeted by the implementation of a randomized controlled trial to improve treatment with oral anticoagulants in patients with atrial fibrillation (impact-afib) .Am Heart J. 2020; 229 : 110-7 . doi: 10.1016/j.ahj.2020.07.012 .
• Garcia C , Haynes K , Pokorney SD et al . Practical challenges in the conduct of pragmatic trials embedded in health plans: lessons of impact-afib, an FDA-CATALYST trial .Clin Trials. 2020; 17 (4) : 360-7 . doi: 10.1177/1740774520928426 .
• Cook M , Beachler DC , Parlett LE et al . Testosterone therapy in relation to prostate cancer in a U.S. commercial insurance claims database .Cancer Epidemiol Biomarkers Prev. 2020; 29 (1) : 236-45 . doi: 10.1158/1055-9965.EPI-19-0619 .

Return to Year List

2019

• Parlett LE , Agiro A , Brown S et al . Drivers of hospital length of stay in medicaid and commercially insured mother-infant pairs with a diagnosis of neonatal abstinence syndrome .Med Care. 2019; 57 (12) : 977-83 . doi: 10.1097/MLR.0000000000001199 .
• Parlett LE , Beachler DC , Lanes S , Hoover R , Cook M . Validation of an algorithm for claims-based incidence of prostate cancer .Epidemiology. 2019; 30 (3) : 466-71 . doi: 10.1097/EDE.0000000000001007 .
• Cocoros NM , Pokorney SD , Haynes K et al . Fda-catalyst-using FDA's Sentinel initiative for large-scale pragmatic randomized trials: approach and lessons learned during the planning phase of the first trial .Clin Trials. 2019; 16 (1) : 90-7 . doi: 10.1177/1740774518812776 .

Return to Year List

2016

• Barrett ES , Parlett LE , Sathyanarayana S , Redmon J , Nguyen RH , Swan SH . Prenatal stress as a modifier of associations between phthalate exposure and reproductive development: results from a multicentre pregnancy cohort study .Paediatr Perinat Epidemiol. 2016; 30 (2) : 105-14 . doi: 10.1111/ppe.12264 .

Return to Year List

2015

• Barrett ES , Parlett LE , Swan SH . Stability of proposed biomarkers of prenatal androgen exposure over the menstrual cycle .J Dev Orig Health Dis. 2015; 6 (2) : 149-57 . doi: 10.1017/S2040174414000646 .

Return to Year List

2014

• Barrett ES , Parlett LE , Wang C , Drobnis EZ , Redmon J , Swan SH . Environmental exposure to di-2-ethylhexyl phthalate is associated with low interest in sexual activity in premenopausal women .Horm Behav. 2014; 66 (5) : 787-92 . doi: 10.1016/j.yhbeh.2014.10.003 .
• Barrett ES , Parlett LE , Windham GC , Swan SH . Differences in ovarian hormones in relation to parity and time since last birth .Fertil Steril. 2014; 101 (6) : 1773-80.e1 . doi: 10.1016/j.fertnstert.2014.02.047 .
• Parlett LE . Data cleaning: longitudinal study cross-visit checks .Sas Glob Forum. 2014; 2014 : 1314 .
• Barrett ES , Parlett LE , Redmon J , Swan SH . Evidence for sexually dimorphic associations between maternal characteristics and anogenital distance, a marker of reproductive development .Am J Epidemiol. 2014; 179 (1) : 57-66 . doi: 10.1093/aje/kwt220 .

Return to Year List

2013

• Barrett ES , Parlett LE , Sathyanarayana S et al . Prenatal exposure to stressful life events is associated with masculinized anogenital distance (agd) in female infants .Physiol Behav. 2013; 114-115 : 14-20 . doi: 10.1016/j.physbeh.2013.03.004 .
• Parlett LE , Swan SH , Calafat AM . Women's exposure to phthalates in relation to use of personal care products .J Expos Sci Environ Epidemiol. 2013; 23 (2) : 197-206 . doi: 10.1038/jes.2012.105 .

Return to Year List

2012

• Kobrosly RW , Parlett LE , Stahlhut RW , Barrett ES , Swan SH . Socioeconomic factors and phthalate metabolite concentrations among United States women of reproductive age .Environ Res. 2012; 115 : 11-17 . doi: 10.1016/j.envres.2012.03.008 .

Return to Year List

2011

• Parlett LE , Bowman JD , van Wijngaarden E . Evaluation of occupational exposure to magnetic fields and motor neuron disease mortality in a population-based cohort .J Occup Environ Med. 2011; 53 (12) : 11-17 . doi: 10.1097/JOM.0b013e318237a1d0 .

Return to Year List